Browse by author
Lookup NU author(s): Joe Emerson, Professor Jarka Glassey
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2020 Elsevier Inc.The emergence of cell gene therapy (CGT) as a safe and efficacious treatment for numerous severe inherited and acquired human diseases has led to growing interest and investment in new CGT products. The most successful of these have been autologous viral vector-based treatments. The development of viral vector manufacturing processes and ex vivo patient cell processing capabilities is a pressing issue in the advancement of autologous viral vector-based CGT treatments. In viral vector production, scale-up is a critical task due to the limited scalability of traditional laboratory systems and the demand for high volumes of viral vector manufactured in accordance with current good manufacturing practice. Ex vivo cell processing methods require optimisation and automation before they can be scaled out, and several other manufacturing challenges are prevalent such as high levels of raw material and process variability, difficulty characterising complex materials, and a lack of knowledge of critical process parameters and their effect on critical quality attributes of the viral vector and cell drug products. Multivariate data analysis (MVDA) has been leveraged successfully in a variety of applications in the chemical and biochemical industries, including for tasks such as bioprocess monitoring, identification of critical process parameters and assessment of process variability and comparability during process development, scale-up and technology transfer. Henceforth, MVDA is reviewed here as a suitable tool for tackling some of the challenges faced in the development of CGT manufacturing processes. A summary of some key CGT manufacturing challenges is provided along with a review of MVDA applications to mammalian and microbial processes, and an exploration of the potential benefits, requirements and pre-requisites of MVDA applications in the development of CGT manufacturing processes.
Author(s): Emerson J, Kara B, Glassey J
Publication type: Review
Publication status: Published
Journal: Biotechnology Advances
Year: 2020
Volume: 45
Online publication date: 25/09/2020
Acceptance date: 22/09/2020
ISSN (electronic): 0734-9750
Publisher: Elsevier Inc.
URL: https://doi.org/10.1016/j.biotechadv.2020.107637
DOI: 10.1016/j.biotechadv.2020.107637
